Table 3.
Management of n = 1879 adolescents with HMB.
| Management strategy | N (%) |
|---|---|
| Hormonal treatment | 1050 (55.9) |
| Combined oral contraceptive | 897 (47.7) |
| Other combined contraceptive | 21 (1.1) |
| Progesterone | 210 (11.2) |
| Estrogena | 8 (0.4) |
| Hormonal IUD | 49 (2.6) |
| Copper IUDb | 3 (0.2) |
| Analgesics | 349 (18.6) |
| Paracetamolc,d | 7 (2.0) |
| NSAIDsc | 340 (97.4) |
| Unspecifiedc | 2 (0.5) |
| Tranexamic acid | 54 (2.9) |
| Iron supplements | 135 (7.2) |
| Combined treatment | 301 (16.0) |
| Hormonal and tranexamic acide | 36 (12.0) |
| Hormonal and iron supplementse | 88 (29.2) |
| Hormonal and NSAIDse | 217 (72.1) |
| Referral to second-/third-line care | 55 (2.9) |
| Pediatricianf | 2 (3.6) |
| Gynecologistf | 47 (85.5) |
| Unspecifiedf | 6 (11.0) |
IUD, intrauterine device; NSAID, nonsteroid anti-inflammatory drug.
a
Combined with: Mirena IUD (n = 1), oral contraceptive microgynon 30/50 (n = 3), oral progesterone (n = 1), and nothing (n = 3).
b
Combined with NSAIDs (n = 3) and oral hormonal contraceptives (n = 1).
c
Absolute number and percentage of analgesics.
d
Paracetamol is the same as acetaminophen.
e
Absolute number and percentage of combined treatment.
f
Absolute number and percentage of total referrals.